Prothrombotic abnormalities in patients with multiple myeloma and monoclonal gammopathy of undetermined significance
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prothrombotic abnormalities in patients with multiple myeloma and monoclonal gammopathy of undetermined significance
Authors
Keywords
Thrombin generation, Tissue factor, Procoagulant phospholipids, Neutrophil extracellular traps, Multiple myeloma, MGUS
Journal
THROMBOSIS RESEARCH
Volume 202, Issue -, Pages 108-118
Publisher
Elsevier BV
Online
2021-03-21
DOI
10.1016/j.thromres.2021.03.015
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Extracellular vesicle-associated procoagulant phospholipid and tissue factor activity in multiple myeloma
- (2019) Thøger Nielsen et al. PLoS One
- Quantification of NETs-associated markers by flow cytometry and serum assays in patients with thrombosis and sepsis
- (2018) K. H. Lee et al. International Journal of Laboratory Hematology
- Baseline and treatment-related changes in thrombin generation in patients with multiple myeloma
- (2016) Ing S. Tiong et al. LEUKEMIA & LYMPHOMA
- NETs in cancer
- (2016) Marzena Garley et al. TUMOR BIOLOGY
- The Danish National Multiple Myeloma Registry
- (2016) Peter Gimsing et al. Clinical Epidemiology
- Contact activation: important to consider when measuring the contribution of tissue factor-bearing microparticles to thrombin generation using phospholipid-containing reagents
- (2014) N. Boknäs et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Differing coagulation profiles of patients with monoclonal gammopathy of undetermined significance and multiple myeloma
- (2014) Maeve P. Crowely et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Thrombosis: tangled up in NETs
- (2013) K. Martinod et al. BLOOD
- Neutrophil extracellular traps
- (2013) Mélanie Demers et al. OncoImmunology
- Thrombosis in multiple myeloma (MM)
- (2012) Cesarman-Maus Hematology
- Low Venous Thromboembolic Risk With Bortezomib in Multiple Myeloma and Potential Protective Effect With Thalidomide/Lenalidomide-based Therapy: Review of Data From Phase 3 Trials and Studies of Novel Combination Regimens
- (2011) Maurizio Zangari et al. Clinical Lymphoma Myeloma & Leukemia
- Hypercoagulability in Multiple Myeloma and Its Precursor State, Monoclonal Gammopathy of Undetermined Significance
- (2011) Sigurdur Yngvi Kristinsson et al. SEMINARS IN HEMATOLOGY
- Bleeding and Thrombosis in Multiple Myeloma and Related Plasma Cell Disorders
- (2011) Antonio Coppola et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Venous thromboembolism in multiple myeloma: Current perspectives in pathogenesis
- (2010) Noppacharn Uaprasert et al. EUROPEAN JOURNAL OF CANCER
- Monoclonal gammopathy of undetermined significance and risk of venous thromboembolism
- (2010) Henrik Gregersen et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma
- (2010) J. J. A. Auwerda et al. THROMBOSIS AND HAEMOSTASIS
- Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study
- (2009) O. Landgren et al. BLOOD
- Levels of microparticle tissue factor activity correlate with coagulation activation in endotoxemic mice
- (2009) J.-G. WANG et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma
- (2008) S. Y. Kristinsson et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More